Encompass Health (NYSE: EHC) director receives 1,634 stock units grant

Rhea-AI Filing Summary

SCHLICHTING NANCY M reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp director Nancy M. Schlichting received an annual grant of 1,634 restricted stock units of Encompass Health Common Stock at no cost under the corporation's 2025 Omnibus Performance Incentive Plan. Following this grant, she directly holds 22,932 shares of Encompass Health Common Stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SCHLICHTING NANCY M

Role null

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	1,634	$0.00	--

Holdings After Transaction: Encompass Health Common Stock — 22,932 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock units granted: 1,634 shares Grant price per share: $0.0000 per share Total shares after transaction: 22,932 shares +1 more

4 metrics

Restricted stock units granted 1,634 shares Annual grant on 2026-05-07

Grant price per share $0.0000 per share Director equity award

Total shares after transaction 22,932 shares Direct holdings following grant

Transaction code Code A Grant, award, or other acquisition

Key Terms

restricted stock units, 2025 Omnibus Performance Incentive Plan, grant, award, or other acquisition

3 terms

restricted stock units financial

"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2025 Omnibus Performance Incentive Plan financial

"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHLICHTING NANCY M

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	05/07/2026		A		1,634(1)	A	$0	22,932	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

	/s/ Patrick Darby, attorney-in-fact for Nancy M. Schlichting	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Encompass Health (EHC) report for Nancy M. Schlichting?

Encompass Health reported that director Nancy M. Schlichting received an annual grant of 1,634 restricted stock units of Encompass Health Common Stock. This grant was made as part of the corporation's 2025 Omnibus Performance Incentive Plan and reflects compensation, not an open-market purchase.

How many Encompass Health (EHC) shares does Nancy M. Schlichting hold after this grant?

After the grant, Nancy M. Schlichting directly holds 22,932 shares of Encompass Health Common Stock. This total includes the newly awarded 1,634 restricted stock units, which were granted at no cost as part of the company’s 2025 Omnibus Performance Incentive Plan for directors.

What type of award did Encompass Health (EHC) grant to its director Nancy M. Schlichting?

Nancy M. Schlichting received an annual grant of restricted stock units representing 1,634 shares of Encompass Health Common Stock. The award was issued at a price of $0.0000 per share under the corporation’s 2025 Omnibus Performance Incentive Plan, indicating a compensation-related equity grant.

Was the Encompass Health (EHC) transaction by Nancy M. Schlichting a market purchase or a compensation grant?

The transaction was a compensation grant, not a market purchase. Nancy M. Schlichting received 1,634 restricted stock units at no cost as an annual award under Encompass Health’s 2025 Omnibus Performance Incentive Plan, reflecting equity-based director compensation rather than an open-market trade.

What does the 2025 Omnibus Performance Incentive Plan mean for Encompass Health (EHC) directors?

The 2025 Omnibus Performance Incentive Plan provides for equity-based awards, such as restricted stock units, to directors and possibly other participants. In this case, Nancy M. Schlichting received an annual grant of 1,634 restricted stock units of Encompass Health Common Stock pursuant to that plan as part of her compensation.